Dexamethasone downregulates Cryptococcus neoformans-induced vascular endothelial growth factor production: A role for corticosteroids in cryptococcal meningitis? [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 37, Issue 3, 2004, Pages 1431-1432

  Hoepelman, Andy I M ^a,b   Van Der Flier, Michiel ^b,c   Coenjaerts, Frank E J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; DEXAMETHASONE; FLUCONAZOLE; GLUCURONOXYLOMANNAN; POLYENE ANTIBIOTIC AGENT; POLYSACCHARIDE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN;

BLINDNESS; BRAIN EDEMA; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRYPTOCOCCUS NEOFORMANS; CRYPTOCOCCUS NEOFORMANS NCPF3168; DRUG EFFECT; FUNGAL MENINGITIS; HUMAN; HUMAN CELL; INTRACRANIAL HYPERTENSION; LETTER; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TUBERCULOUS MENINGITIS; VISUAL IMPAIRMENT;

ADRENAL CORTEX HORMONES; CRYPTOCOCCOSIS; DEXAMETHASONE; HUMANS; MENINGITIS, CRYPTOCOCCAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 7244238018     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000137411.23705.7a     Document Type: Letter

References (14)

1. Casadevall A, Perfect JR. Cryptococcus neoformans. Washington, DC: ASM Press; 1998.
2. Vilchez RA, Fung J, Kusne S. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant. 2002;2:575-580.
3. Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7:375-381.
4. Bennett JE, Dismukes WE, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med. 1979;301:126-131.
5. Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 2000;30:710-718.
6. Van Bruggen N, Thibodeaux H, Palmer JT, et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest. 1999;104:1613-1620.
7. Van der Flier M, Stockhammer G, Vonk GJ, et al. Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. J Infect Dis. 2001;183:149-153.
8. Matsuyama W, Hashiguchi T, Umehara F, et al. Expression of vascular endothelial growth factor in tuberculous meningitis. J Neural Sci. 2001;186:75-79.
9. Girgis NI, Farid Z, Kilpatrick Y, et al. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J. 1991;10:179-183.
10. Schoeman J, Elshof J, Laubscher J, et al. The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Ann Trop Paediatr. 2001;21:299-305.
11. Heiss JD, Papavassiliou E, Merrill MJ, et al. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. J Clin Invest. 1996;98:1400-1408.
12. Hirano A, Zimmerman HM, Levine S. Fine structure of cerebral fluid accumulation. V. Transfer of fluid from extracellular compartments in acute phase of cryptococcal polysaccharide lesions. Arch Neurol. 1964;11:632-641.
13. Coenjaerts F, Van der Flier M, Mwinzi PNM, et al. Intrathecal production and secretion of vascular endothelial growth factor (VEGF) during cryptococcal meningitis. J Infect Dis. 2004;190:1310-1317.
14. Seaton RA, Verma N, Naraqi S, et al. The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis. Trans R Soc Trop Med Hyg. 1997;91:50-52.